Latest News
Walgreens boosts specialty drug network to 265 therapies, reinforcing its independent market position.
Via Benzinga · August 19, 2025
General Motors is taking strategic steps, such as production relocation, to mitigate tariff impact, Dan Ives said.
Via Benzinga · August 19, 2025
Via Benzinga · August 19, 2025
Target Hospitality Rallies 9% After Stifel Upgrade On Multi-Year Deal For Data Center Campus Support: Retail’s Not Convincedstocktwits.com
Via Stocktwits · August 19, 2025
Shares of Rocket Lab are trading lower Tuesday morning. A key catalyst in recent sessions has been the completed acquisition of Geost.
Via Benzinga · August 19, 2025
Ford Considers Offloading Excess Battery Capacity As EV Market Weakens: Reportstocktwits.com
Via Stocktwits · August 19, 2025
Nvidia-Backed Databricks Lands Massive $100B Valuation As AI Demand Surgesstocktwits.com
Via Stocktwits · August 19, 2025
Sui Lists On Robinhood, Crypto Token Struggles To Break Resistancestocktwits.com
Via Stocktwits · August 19, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · August 19, 2025
Joby's recent piloted flight between two public airports signals significant progress, suggesting the stock's consolidation offers a strategic entry point.
Via MarketBeat · August 19, 2025
Palantir stock fell for the fifth straight trading session on Tuesday. With the retreat, Palantir stock is down 12% from its all-time high.
Via Investor's Business Daily · August 19, 2025
Amer Sports tops second quarter estimates and lifts 2025 outlook as tariff impact remains "negligible."
Via Benzinga · August 19, 2025
Via Benzinga · August 19, 2025
Competition among the makers of weight loss treatments is intensifying.
Via The Motley Fool · August 19, 2025
The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · August 19, 2025
Unicorn companies are making a comeback fueled by the generative AI frenzy.
Via Talk Markets · August 19, 2025
Via Benzinga · August 19, 2025
Here are three stocks to buy now that could offer investors upside in the long term.
Via The Motley Fool · August 19, 2025
Every quarter, we get to see what the best of the best have bought and sold.
Via The Motley Fool · August 19, 2025
KindlyMD Inc.
Via Benzinga · August 19, 2025
Between AI-powered travel planning, a long-term global flights partnership, aggressive buybacks, and strong international growth, Booking Holdings is quietly positioning itself for something bigger than most investors notice at first glance.
Via Talk Markets · August 19, 2025
Lutnick Says US May Take Intel Stake To Counter China Risk, Highlights Nvidia CEO’s Active Role In Chip Policystocktwits.com
Via Stocktwits · August 19, 2025
Via Benzinga · August 19, 2025
Via Benzinga · August 19, 2025
Investing in ETFs doesn't mean you have to sacrifice return potential.
Via The Motley Fool · August 19, 2025
Markets have been very slowly climbing a wall of worry over the past few weeks.
Via Talk Markets · August 19, 2025
Black Hills Corp. and NorthWestern Energy plan to merge in all-stock, tax-free deal to create a $7.8B regulated utility giant serving 2.1M customers in 8 states.
Via Benzinga · August 19, 2025
Here are two stocks to buy now that could offer investors upside in the short and long terms.
Via The Motley Fool · August 19, 2025
Via Benzinga · August 19, 2025
Whether its folly or prescience, markets continue to climb a wall of worry, effectively looking through tariffs and other risk factors that could threaten the bullish trend. But the broad trend from a global perspective remains positive.
Via Talk Markets · August 19, 2025
Wondering if Polkadot deserves a spot in your portfolio? See why this coin could be poised for a breakout in 2026.
Via The Motley Fool · August 19, 2025
GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new partnership with Novo Nordisk.
Via Benzinga · August 19, 2025
Via Benzinga · August 19, 2025
Via Benzinga · August 19, 2025
Via Benzinga · August 19, 2025